Tradestie Institutional Equity Comparison Engine

NUVB vs ATAI โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATAI Overall Edge

ATAI Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to ATAI Life Sciences N.V. Common Shares (ATAI) driven by superior Momentum & Technical, Options & Structure while NUVB counters with relative strength in Growth & Margin. Fundamentally, NUVB trades at N/M Forward P/E with -61.2% operating margin (+242.6% YoY revenue) versus ATAI at N/M Forward P/E and -2590.4% operating margin (+137.0% YoY). In options structure, NUVB sits in BREAKDOWN (26th %ile IV; Dealer Gamma Walls on Pro) against ATAI sits in UNCLASSIFIED (38th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
NUVB N/M vs ATAI N/M Fwd P/E
Growth & Margin Winner NUVB
Op Margin -61.2% vs -2590.4% ยท YoY +242.6% vs +137.0%
Momentum & Technical Winner ATAI
1Y -46.9% vs +50.3% ยท 52W Pos 2% vs 98%
Options & Structure Winner ATAI
BREAKDOWN (26th %ile IV) vs UNCLASSIFIED (38th %ile IV)
NUVB NYSE
Nuvation Bio Inc.
Pharmaceutical Preparations
$3.80
-0.26% 1D
Market Cap $1.3B
1M Return -19.15%
1Y Return -46.85%
Forward P/E N/M
Unified AI Score
61.0 / 100 BUY
Tech 53.0 Fund 61.0 Flow 67.0 Mom 64.0
ATAI NASDAQ
ATAI Life Sciences N.V. Common Shares
Pharmaceutical Preparations
$7.35
+0.82% 1D
Market Cap $2.7B
1M Return +1.94%
1Y Return +50.31%
Forward P/E N/M
Unified AI Score
45.7 / 100 HOLD
Tech 34.0 Fund 47.0 Flow 59.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: NUVB -46.85% ATAI +50.31% Spread: +104.58 pp (ATAI Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period NUVB Revenue ATAI Revenue NUVB Op. Margin ATAI Op. Margin Margin Edge
FY2024 $10M $0M -7527.3% -33341.2% NUVB
FY2025 $60M $0M -338.7% -15751.1% NUVB

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: NUVB (4) vs ATAI (4)
Institutional Metric NUVB ATAI Criterion Row Winner
Market Capitalization Scale $1.3B $2.7B Larger Scale ATAI
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +242.6% +137.0% Higher Growth NUVB
Operating Margin (TTM) Profitability -61.2% -2590.4% Higher Margin NUVB
Net Profit Margin Profitability -67.4% 0.0% Higher Margin ATAI
Return on Equity (ROE) Capital Efficiency -49.1% -417.2% Higher ROE NUVB
52-Week Range Position Momentum 2% ($4โ€“$10) 98% ($3โ€“$7) Stronger Trend ATAI
Beta / 30D Volatility Risk Regime 1.52ฮฒ ยท 55% Vol 1.00ฮฒ ยท 10% Vol Lower Realized Risk ATAI
Unified Institutional Score Composite Signal 61.0 / 100 (BUY) 45.7 / 100 (HOLD) Higher Composite NUVB

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full NUVB vs ATAI Buy Guide
NUVB BREAKDOWN
105d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 26th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live NUVB Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ATAI UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 38th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATAI Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither NUVB nor ATAI registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.